Categories: News

NYSE Content Advisory: Pre-Market update + CEO survey reveals growth as top priority

NEW YORK, May 28, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on May 28th

- Advertisement -
  • The NYSE teamed up with Oliver Wyman for a second straight year to survey top executives. It found that leaders are increasingly focused on growth. Of the 165 NYSE-listed company CEOs that participated, 68% cited a growth driver as priority.
  • Stocks are little changed Wednesday morning as traders await earnings from Nvidia after the closing bell. Markets are anticipating what China restrictions mean for the AI chipmaker. Nvidia hasn’t seen any slow in demand for its graphic processors.
  • Macy’s (NYSE: M), Dick’s Sporting Goods (NYSE: DKS), and Abercrombie & Fitch (NYSE: ANF) released earnings results. Most exceeded expectations during Q1, but traders are tuned into their outlook amid tariffs.

Click here to read the NYSE-Oliver Wyman Survey

- Advertisement -

Opening Bell
The New York Stock Exchange welcomes LTC Properties (NYSE: LTC) to ring the opening bell.

- Advertisement -

Closing Bell
Measured Risk Portfolios celebrates SNTH (NYSE Arca: SNTH)

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2697898/NYSE_Market_Update_May_28.mp4
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–ceo-survey-reveals-growth-as-top-priority-302467133.html

- Advertisement -

Recent Posts

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded…

6 hours ago

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc., a clinical-stage biopharmaceutical…

6 hours ago

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq ListingRule 5635(c)(4)

August 15, 2025 16:05 ET  | Source: X4 Pharmaceuticals BOSTON, Aug. 15, 2025 (GLOBE NEWSWIRE)…

6 hours ago

Automobili Lamborghini Unveils Fenomeno, a New Limited Production Masterpiece at The Quail, A Motorsports Gathering

Produced in just 29 units, the Fenomeno is the most powerful V12 model Lamborghini has…

6 hours ago

Mohamed bin Zayed University of Artificial Intelligence begins new academic year with largest-ever cohort of 400+ students

ABU DHABI,UAE, Aug. 16, 2025 /PRNewswire/ -- Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)…

13 hours ago

XPPen Celebrates 20th Anniversary with “Back to Future, Create Now!”

XPPen & PUBG MOBILE Ultimate Set Design Contest: Leading a New Wave of Creativity LOS…

17 hours ago